Table 1.

Clinicopathologic correlation of CPGL-B expression in human HCC

VariablesUnderexpression of CPGL-B (≥2-fold), n (%)Normal expression, n (%)P
Tumor microsatellite formation
    Present26 (76.5)24 (43.6)0.004*
    Absent8 (23.5)31 (56.4)
Venous invasion
    Present25 (71.4)25 (45.5)0.018*
    Absent10 (28.6)30 (54.5)
Cellular differentiation (by Edmondson)
    Grades 1 and 27 (24.1)22 (46.8)0.056
    Grades 3 and 422 (75.9)25 (53.2)
Tumor size (cm)
    <57 (24.1)20 (42.6)0.140
    >522 (75.9)27 (57.4)
Tumor stage
    I and II7 (25)19 (41.3)0.210
    III and IV21 (75)27 (58.7)
Tumor Encapsulation
    Present9 (25.7)22 (40.7)0.176
    Absent26 (74.3)32 (59.3)
Serum HBsAg
    Present25 (75.8)42 (77.8)1.000
    Absent8 (24.2)12 (22.2)